LRMR
LRMR
US5171251003
Larimar Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
172.497.000 90.890.000
89.8%
Operating Income -172.497.000 -90.890.000
89.8%
Pretax Income -165.673.000 -80.604.000
105.5%
Net Income Common Stockholders -165.673.000 -80.604.000
105.5%
-- --
--
-- --
--
ende